Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
about
Activated protein C: A regulator of human skin epidermal keratinocyte functionAssociation of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysisCytotoxic proteins and therapeutic targets in severe cutaneous adverse reactionsStevens-johnson syndrome associated with drugs and vaccines in children: a case-control studyIdentification of risk factors for carbamazepine-induced serious mucocutaneous adverse reactions: A case-control study using data from spontaneous adverse drug reaction reports.Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.Clinical considerations for epidermal necrolysis.Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of ChinaCost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai populationAssociation of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis.Cephazolin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin and N-acetylcysteineOutbreak of Mycoplasma pneumoniae-Associated Stevens-Johnson Syndrome.A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivityHealthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in ThailandLyell's Syndrome and Antimalarials: A Case Report and Clinical Review.Recurrent Aphthous Stomatitis: A Review.Dermatological manifestations and relationship to outcomes of patients admitted to a medical intensive care unit: a study from a tertiary care hospital in India.Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.Building a microphysiological skin model from induced pluripotent stem cells.Purpura Fulminans in Toxic Epidermal Necrolysis: Case Report and Review.Mycoplasma-associated Stevens-Johnson syndrome in children: retrospective review of patients managed with or without intravenous immunoglobulin, systemic corticosteroids, or a combination of therapies.Pediatric Toxic Epidermal Necrolysis: Experience of a Tertiary Burn Center.Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).Toxic epidermal necrolysis induced by lamotrigine treatment in a child.Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink.Co-amoxiclav-induced Stevens Johnson syndrome in a child.Determination of the Potential of Drug Candidates to Cause Severe Skin Disorders Using Computational Modeling.Amoxycillin and clavulanic acid induced Stevens-Johnson syndrome: A case report.Stevens-Johnson Syndrome triggered by a combination of clobazam, lamotrigine and valproic acid in a 7-year-old child.Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia.Biological skin substitutes to treat toxic epidermal necrolysis in a case with human immunodeficiency virus infectionAssociation of natural killer cell dysfunction and recurrent Stevens-Johnson syndrome in a pediatric patient.Combination of Steven-Johnson syndrome and neuroleptic malignant syndrome following carbamazepine therapy: a rare occurrence.Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS-TEN overlap and potential drug-drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital.Rapidly developing toxic epidermal necrolysis.Drug-induced Skin Lesions in Cynomolgus Macaques Treated with Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulators.Stevens-Johnson syndrome and toxic epidermal necrolysis in children.The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
P2860
Q26830499-4908E6BB-378E-42A6-AA8F-4F0738EDF644Q26853305-648D18FE-1EAF-47DB-96BF-9C6115136FC3Q28395744-6E7C9EC0-A19C-4FA4-8B43-2601E3FA1ED2Q28534684-C5A4B380-EC3F-4CBE-9D10-4FE960B16FA4Q30814834-917A6E12-4720-4CDE-B12E-8F991599C432Q33655940-FA29FFA9-A4B7-4098-BF3F-EDCCAF7BEB99Q33879666-978E7974-4355-4E2F-90DC-1EE7EDCC2A5EQ34228624-17F4F079-9B95-4E83-92BA-09CBF2B3699DQ34742870-4AAD9329-D4B2-4019-AA60-FF9339C180E0Q35147703-5964953D-9E60-42A9-A595-84B286B7A24FQ35453569-890F67A4-E326-4048-9E48-ED1305640251Q35545025-38D5A973-387B-485D-A0FD-F794A0516762Q35894759-C548A8DB-3995-4889-992E-22C562308ADEQ36370958-F764EE78-C3CD-4EEA-A361-A44D2BAE73ABQ37093603-EF79314E-F55A-4B33-AFBA-B20A1583544AQ37671321-9C82639C-987B-4A7F-9F97-75A71B4044BDQ37723069-5102E69E-4ED2-4DF3-BF13-63E97528FDBBQ38094011-53D1EB70-7E5E-45B4-B06D-6B898B013A05Q38118508-BE4B1E9F-9B09-4614-A43F-DD160BE68A85Q38190637-D38EAF5D-21D8-412E-A3F6-1908D986E72DQ38269913-A9FF0035-25CF-4349-9093-20B52D9CAA45Q38271345-42A70E47-88A9-4371-A10E-23C1713C6883Q38557883-D817C8DB-C3B8-4D55-91BB-B1E68665B950Q38654435-3B5227C3-6478-444C-9107-8BE0BE50EB51Q38867084-267877B9-6606-4B7E-B52E-BBC063637424Q38983703-AA3A9BEE-EC39-4D2A-BDA6-DC4F9BB4B390Q39015038-F68F3DCF-70C8-43CE-A7E5-45DFE1F648AAQ39461397-0484DE4D-C57B-4F2E-9ADC-0EF2D74A88DEQ39535536-242B6E49-AFC8-4018-ADCC-6AA8E7461009Q40084899-3AC868C4-1ABA-4823-A276-1E255CDD1365Q40147488-E6CC3C3F-A129-43F5-B737-1BE59983FE55Q40271934-BF01402D-A25C-49ED-88AB-566CADF8D29EQ41750048-FE8DDA20-E6D5-47C3-8BDC-030B50D43B69Q41899323-8C982D65-CC17-462F-A39B-9A0122664DB4Q42265601-C6A4F3E8-F71D-4D60-BA87-FDD1F1FFA16BQ42339143-472F4954-9169-4BD6-B4A4-7CD60A768F73Q42606892-1DF49D26-CEC4-49B3-828F-08EDBE905992Q46030428-D706BB1D-2D4C-487A-9034-E0A784BCB32AQ46536194-08C8AE44-A60C-4577-B03D-55661A7455EAQ47652420-23F4EF8D-2689-4095-80F6-057F01A09D7B
P2860
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
@en
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
@nl
type
label
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
@en
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
@nl
prefLabel
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
@en
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
@nl
P2093
P1476
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
@en
P2093
Mathias Nelle
Roland Gerull
Thomas Schaible
P304
P356
10.1097/CCM.0B013E31821201ED
P407
P577
2011-06-01T00:00:00Z